Morris, V. K., Donate, M. C., Seligmann, J., Takashima, A., Arnold, D., Dudzisz-Sledz, M., Pulini, J., Tian, C., Karasic, T. B., Parikh, A. R. (2026). INCA033890-303: A randomized, double-blind, phase 3 study of FOLFOX and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite-stable colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3683